What are Insight Molecular Diagnostics Inc. Common Stock's profit margins?

Insight Molecular Diagnostics Inc. Common Stock (IMDX) runs a 51.3% gross margin and a -2500.7% operating margin, with a -2454.6% net margin.

Where do Insight Molecular Diagnostics Inc. Common Stock's ratios come from?

Every ratio is computed from Insight Molecular Diagnostics Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Insight Molecular Diagnostics Inc. Common Stock IMDX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	51.3%-5.7pp	57%+1.7pp	55.2%-0.3pp	55.5%+1.3pp	54.3%+10.3pp
Operating margin	-2,500.7%-1,240pp	-1,260.8%+132pp	-1,392.9%+105pp	-1,498.3%+25.8pp	-1,524.1%+1,721pp
Net margin	-2,454.6%-1,216pp	-1,238.5%+142pp	-1,380.7%+109pp	-1,489.7%+24.9pp	-1,514.6%+1,710pp
EBITDA margin	-2,380.8%-1,174pp	-1,206.8%+137pp	-1,343.7%+110pp	-1,453.6%+27.7pp	-1,481.3%+1,685pp
Free cash flow margin	-1,409.7%-784pp	-625.6%-82.5pp	-543.2%+20.0pp	-563.2%+48.2pp	-611.4%+516pp
Returns
Return on assets	-94.9%+70.2pp	-165.1%-58.6pp	-106.5%-5.2pp	-101.3%-12.6pp	-88.6%+21.7pp
Efficiency
Asset turnover	0×-0.1×	0.1×+0.1×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Inventory turnover	2.3×-1.8×	4.1×-1.5×	5.6×—	——	——
Liquidity
Current ratio	2.5×+1.3×	1.3×-1.5×	2.8×-1.2×	4×+0.3×	3.7×+2.1×
Quick ratio	2.5×+1.3×	1.2×-1.5×	2.7×-1.2×	3.9×+0.2×	3.7×+2.1×
Cash ratio	2.3×+1.4×	1×-1.5×	2.4×-1.2×	3.7×+0.4×	3.2×+2.0×
Leverage
Debt-to-assets	0.1×-0.1×	0.1×+0.1×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Per Share
Book value per share	-$0.31+70.0%	-$1.03-260%	-$0.29-937%	$0.03-91.4%	$0.40+142%
Valuation
Market capitalization	$185.35M+92.3%	$214.98M+126%	$95.02M-3.7%	$98.67M—	——
Enterprise value	$160.03M+113%	$206.72M+161%	$79.27M+2.2%	$77.58M—	——
Price / sales	95.1×+72.5×	53×+31.4×	21.6×-1.6×	23.2×—	——
EV / sales	82.1×+64.4×	51×+33.0×	18×-0.2×	18.2×—	——
Free cash flow yield	-14.8%+10.1pp	-11.8%+13.4pp	-25.2%-0.9pp	-24.3%—	——
Earnings yield	-25.8%+40.0pp	-23.4%+40.6pp	-64%+0.3pp	-64.3%—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Insight Molecular Diagnostics Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Insight Molecular Diagnostics Inc. Common Stock's profit margins?: Insight Molecular Diagnostics Inc. Common Stock (IMDX) runs a 51.3% gross margin and a -2500.7% operating margin, with a -2454.6% net margin.
Where do Insight Molecular Diagnostics Inc. Common Stock's ratios come from?: Every ratio is computed from Insight Molecular Diagnostics Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.